Plus   Neg

United Airlines Sees 75% Lower Scheduled Capacity For July 2020 - Quick Facts

United Airlines, Inc. (UAL) announced Tuesday that it has seen a reduction in customer cancellation rates and a moderate improvement in demand in the Domestic U.S. and certain international destinations for the remainder of the second quarter of 2020.

In April, the company experienced gross bookings that were down over 95 percent compared to April 2019, with customer cancellation rates reaching unprecedented highs.

Looking ahead, the company expects its scheduled capacity, relative to 2019 levels, for July 2020 to be down approximately 75 percent. Scheduled capacity for May and June 2020 were reduced by approximately 90 percent from 2019 levels.

The company plans to continue to proactively evaluate and cancel flights on a rolling 60-day basis until it sees signs of a recovery in demand.

The company also noted that it continues to expect total adjusted capital expenditures for 2020 to be below $4.5 billion. It currently expects total adjusted capital expenditures for 2021 to be close to $2 billion.

As previously disclosed, the company plans to only take delivery of aircraft that are fully financed. In 2022, the company does not expect to be required to take delivery of any new aircraft and expects that non-aircraft adjusted capital expenditures will not exceed $500 million.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said that the current state of the COVID-19 pandemic in the U.S. is "really not good." The U.S. is the country worst-affected by the coronavirus and has recently seen a surge in coronavirus infections as lockdown restrictions are eased. Granules Pharmaceuticals, Inc. recalled twelve (12) lots of type 2 diabetes medication Metformin hydrochloride Extended-Release, in the form of oral film-coated tablets, for the potential presence of nitrosamine impurity, N-Nitrosodimethylamine (NDMA), above levels of the Acceptable Daily Intake Limit (ADI), the U.S. Food and Drug Administration or FDA said in a statement. Palantir Technologies Inc., the Silicon Valley big data analytics company that has handled U.S. government's certain sensitive projects, said it has confidentially filed documents with the Securities and Exchange Commission to go public. In a statement, the company said the proposed public listing of its Class A common stock is expected to take place after the SEC completes its review process.
Follow RTT